Search Results

You are looking at 1 - 10 of 654 items for :

Clear All
Full access

Natalie Moryl, Nessa Coyle, Samuel Essandoh and Paul Glare

U nfortunately, some cancer survivors with chronic cancer-related pain meet significant barriers limiting their access to medications previously determined effective and well-tolerated. An unintended consequence is pain that had been well

Full access

Robert Swarm, Amy Pickar Abernethy, Doralina L. Anghelescu, Costantino Benedetti, Craig D. Blinderman, Barry Boston, Charles Cleeland, Nessa Coyle, Oscar A. deLeon-Casasola, June G. Eilers, Betty Ferrell, Nora A. Janjan, Sloan Beth Karver, Michael H. Levy, Maureen Lynch, Natalie Moryl, Barbara A. Murphy, Suzanne A. Nesbit, Linda Oakes, Eugenie A. Obbens, Judith A. Paice, Michael W. Rabow, Karen L. Syrjala, Susan Urba and Sharon M. Weinstein

Overview Pain, defined as “a sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage,” 1 is one of the most common symptoms associated with cancer. Cancer pain or cancer

Full access

Robert A. Swarm, Amy Pickar Abernethy, Doralina L. Anghelescu, Costantino Benedetti, Sorin Buga, Charles Cleeland, Oscar A. deLeon-Casasola, June G. Eilers, Betty Ferrell, Mark Green, Nora A. Janjan, Mihir M. Kamdar, Michael H. Levy, Maureen Lynch, Rachel M. McDowell, Natalie Moryl, Suzanne A. Nesbit, Judith A. Paice, Michael W. Rabow, Karen L. Syrjala, Susan G. Urba, Sharon M. Weinstein, Mary Dwyer and Rashmi Kumar

appropriate. All recommendations are category 2A unless otherwise noted. Clinical trials: NCCN believes that the best management for any cancer patient is in a clinical trial. Participation in clinical trials is especially encouraged. Overview Pain

Full access

Augusto Caraceni, Andrew Davies, Philippe Poulain, Hernán Cortés-Funes, Sunil J. Panchal and Guido Fanelli

Adequate Pain Management: A Fundamental Human Right Recognition of the prevalence and impact of pain has spread to policymakers and health care providers worldwide. In 2010, the first International Pain Summit was held in conjunction with the

Full access

Alyssa A. Schatz, Thomas K. Oliver, Robert A. Swarm, Judith A. Paice, Deepika S. Darbari, Deborah Dowell, Salimah H. Meghani, Katy Winckworth-Prejsnar, Eduardo Bruera, Robert M. Plovnick, Lisa Richardson, Neha Vapiwala, Dana Wollins, Clifford A. Hudis and Robert W. Carlson

Opioids are an established and effective tool in the armamentarium of pain relief strategies for the management of complex, acute, and/or persistent pain in select disease-specific patient populations. However, in recent years the escalation of

Full access

Jana Portnow, Christine Lim and Stuart A. Grossman

None of the authors have received any financial support for this study. References 1 McGrath PJ Hsu E Cappelli M . Pain from pediatric cancer: a survey of an outpatient oncology clinic . J Psychosoc Oncol 1990 ; 8 : 109

Full access

Carlos J. Roldan, Matthew Chung, Lei Feng and Eduardo Bruera

stem cell transplantation (SCT). 1 Oral lesions cause pain, resulting in dehydration, malnutrition, medication noncompliance, interruption in therapy, or increased risk of infection. Pain caused by OM may lead to impairment of oral function, which may

Full access

Judith A. Paice

How do you provide good pain control and, at the same time, ensure that our patients are safe?” asked Judith A. Paice, PhD, RN, Director of the Cancer Pain Program, Division of Hematology-Oncology, and Research Professor of Medicine, Feinberg

Full access

Robert A. Swarm

of Pain Management at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine and Chair of the NCCN Panel on Adult Cancer Pain. The key current goals for controlling cancer pain are to 1) fully integrate symptom

Full access

Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Kristin Leonardi-Warren, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O’Connor, Linda Overholser, Electra D. Paskett, Muhammad Raza, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole McMillian and Deborah Freedman-Cass

appropriate. All recommendations are category 2A unless otherwise noted. Clinical trials: NCCN believes that the best management for any cancer patient is in a clinical trial. Participation in clinical trials is especially encouraged. Pain in Survivors